Cancer Gene Therapy - Table of Contents alert Volume 19 Issue 2

TABLE OF CONTENTS Volume 19, Issue 2 (February 2012) In this issue Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Nature Reviews Genetics ANIMATION ON RNA INTERFERENCE Nature Reviews Genetics, in association with Arkitek Studios, has brought RNAi to life in this vivid, audio-visual journey into the cell. See RNAi in action by viewing the animation for FREE at: www.nature.com/nrg/multimedia/rnai Produced with support from Thermo Scientific   Original Articles Top Tumor-targeted gene therapy using Adv-AFP-HRPC/IAA prodrug system suppresses growth of hepatoma xenografted in mice M Dai, J Liu, D-E Chen, Y Rao, Z-J Tang, W-Z Ho and C-Y Dong Cancer Gene Ther 2012 19: 77-83; advance online publication, September 30, 2011; 10.1038/cgt.2011.65 Abstract | Full Text Retargeting NK92 cells using an HLA-A2-restricted, EBNA3C-specific chimeric antigen receptor D V Tassev, M Cheng and N-KV Cheung Cancer Gene Ther 2012 19: 84-100; advance online publication, October 7, 2011; 10.1038/cgt.2011.66 Abstract | Full Text VSV-MP gene therapy strategy inhibits tumor growth in nude mice model of human lung adenocarcinoma X-M Jing, Y-J Wen, W Shi, Q-Q Tang, J Li and X-C Chen Cancer Gene Ther 2012 19: 101-109; advance online publication, November 4, 2011; 10.1038/cgt.2011.71 Abstract | Full Text Mc-hES, a novel plasmid carrying human endostatin gene, inhibits nasopharyngeal carcinoma growth B-L Xu, L Yuan, J-X Wu, N Xu, W-J Fang, P Zhao and W-L Huang Cancer Gene Ther 2012 19: 110-117; advance online publication, December 9, 2011; 10.1038/cgt.2011.72 Abstract | Full Text Efficient antitumor effects of carrier cells loaded with a fiber-substituted conditionally replicating adenovirus on CAR-negative tumor cells K Iguchi, F Sakurai, K Tomita, K Katayama, T Yamaguchi, K Kawabata, M Tagawa, M Kawabata, T Shirakawa and H Mizuguchi Cancer Gene Ther 2012 19: 118-125; advance online publication, November 11, 2011; 10.1038/cgt.2011.74 Abstract | Full Text Macrophage metalloelastase (MME) as adjuvant for intra-tumoral injection of oncolytic adenovirus and its influence on metastases development S Lavilla-Alonso, M M T Bauer, U Abo-Ramadan, A Ristimäki, J Halavaara, R A Desmond, D Wang, S Escutenaire, L Ahtiainen, K Saksela, T Tatlisumak, A Hemminki and S Pesonen Cancer Gene Ther 2012 19: 126-134; advance online publication, November 18, 2011; 10.1038/cgt.2011.76 Abstract | Full Text The antitumor effects of adenoviral-mediated, intratumoral delivery of interleukin 23 require endogenous IL-12 J Reay, A Gambotto and P D Robbins Cancer Gene Ther 2012 19: 135-143; advance online publication, December 9, 2011; 10.1038/cgt.2011.78 Abstract | Full Text E10A, an adenovirus-carrying endostatin gene, dramatically increased the tumor drug concentration of metronomic chemotherapy with low-dose cisplatin in a xenograft mouse model for head and neck squamous-cell carcinoma Z Adhim, X Lin, W Huang, N Morishita, T Nakamura, H Yasui, N Otsuki, K Shigemura, M Fujisawa, K Nibu and T Shirakawa Cancer Gene Ther 2012 19: 144-152; advance online publication, November 25, 2011; 10.1038/cgt.2011.79 Abstract | Full Text Advertisement Cell Signaling, Disease and Stem Cells Special Issue and Web Focus The January special issue of Cell Research and the accompanying web focus in the field of Cell Signaling, Disease and Ste Cells present recent advances in various aspects of cell signalling and stem cell biology, and their relevance to disease pathogenesis. Access the Cell Signaling, Disease and Stem Cells Web Focus today!   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.